Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
For over 4 months, we have been in the privileged position of witnessing real-time trends in the literature via our weekly curation of The Neurology and Neuropsychiatry of COVID-19 blog.1 There is an emerging recognition of the need to report the severity and outcomes of neurological complications of SARS-CoV-2 infection. Stroke is a rare but well-documented complication, with most prevalence estimates varying slightly around 0.8%.2 It is therefore important to elucidate both those at risk of developing stroke and stratifying those at risk of more severe outcomes when stroke occurs.
We were greatly interested to read the letter by Dmytriw et al,3 which highlighted potential racial disparities in outcomes from ischaemic stroke after COVID-19. Their novel study built on the hypothesis that black and minority ethnic (BAME) individuals have poorer outcomes from COVID-19 in general.4 An editorial commentary by Renieri5 further highlighted the need to elucidate mechanisms that may drive an interaction between stroke and COVID-19 to explain increased mortality in ethnic minorities. Previously also, Katz et al reported that patients with stroke with COVID-19 were more likely to be from a BAME population than patients with stroke without COVID-19. The potential over-representation of BAME individuals in COVID-19 stroke cohorts …
Twitter @danish_hafeez1, @Tim_R_Nicholson
Collaborators The SARS-COV-neuro collaboration: Ben Cross, Benedict Michael, Emma Rengasamy, Hamilton Morrin, Jamie Badenoch, Lucretia Thomas, Mao Fong Lim, Mark Ellul, Matt Butler, Tom Pollak, Susannah Pick.
Contributors DH came up with the initial idea. DH, JS, CW, AR and TRN all contributed to the final manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.